A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
Condition: Bioequivalence Interventions: Drug: Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use; Drug: Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use Sponsors: Pharmtechnology LLC; Altasciences Company Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials